Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
7.30
-0.61 (-7.71%)
At close: Apr 28, 2026, 4:00 PM EDT
7.90
+0.60 (8.22%)
After-hours: Apr 28, 2026, 7:25 PM EDT
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $642.47 million as of April 28, 2026. Its market cap has increased by 265.14% in one year.
Market Cap
642.47M
Enterprise Value
583.07M
1-Year Change
265.14%
Ranking
Category
Stock Price
$7.30
Market Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $642.47M, an increase of 85.05%. That is a compound annual growth rate of 12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 696.16M | 64.94% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 765.10M |
| Tenax Therapeutics | 760.04M |
| Absci | 742.15M |
| Solid Biosciences | 737.96M |
| Relmada Therapeutics | 737.36M |
| Lexicon Pharmaceuticals | 716.02M |
| BridgeBio Oncology Therapeutics | 703.49M |
| Gyre Therapeutics | 696.73M |